Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

Status unconfirmed

Conditions studied: Insulin Dependent Diabetes, Non Insulin Dependent Diabetes, Gestational Diabetes

In brief

Comparison of noninvasive glucose measurement performance versus standard invasive reference measurements.

Key facts

Study ID

NCT01745900

Run by

VeraLight, Inc.

People needed

125

Starts

2012-12-01

Expected to finish

2013-03-01

Last updated by the study team

2012-12-10

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female aged ≥ 18 and ≤ 50 years of age at time of enrollment
• Females with self reported diagnosis of Type I, Type II or Gestational Diabetes, or no self reported diagnosis of diabetes.

You may not qualify if…

• Severe heart disease as evidenced by peripheral edema (self reported)
• Currently taking Lasix (self reported)
• Liver disease as evidenced by jaundice (self reported)
• Receiving dialysis or having known renal compromise (self reported)
• Skin damage at optical sampling site
• Scars, tattoos, rashes or other disruption/discoloration on the right index finger
• Recent (within past month) or current oral steroid therapy or topical steroids applied to the hands; inhaled steroid therapy (self reported)
• Current chemotherapy, or chemotherapy within the past 12 months (self reported)

Where it is running

• Accelovance Inc. — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.